Angiotech Suspends Drug-Eluting Vascular Wrap Trials Over Safety Signals
This article was originally published in The Gray Sheet
Executive Summary
Angiotech suspended enrollment April 21 in U.S. and European pivotal trials of its drug-eluting vascular graft mesh wrap due to safety concerns